Virax Biolabs Group Limited (VRAX)
NASDAQ·Healthcare·Biotechnology
$0.13
-5.17%
Mkt Cap $868.39K
Next Earnings
In 36 daysWed, Jun 3, 2026
EPS Estimate
-$0.07
1 analysts
Revenue Estimate
$1.40K
EPS — Estimate vs Actual
Mkt Cap
$868.39K
P/E
—
Fwd P/E
—
P/S
194.56
Rev TTM
—
EPS TTM
-$1.18